All Clinical Research

The latest research using Kate Farms

View top level findings and download detailed abstracts.

Latest Research from ASPEN 2023 (P29)

More Than Solubility: Understanding Clinical Implications of Updated Analytical Testing of Dietary Fiber Within Enteral Nutrition Formulas

Updated testing methodologies for detecting dietary fiber has revealed an increase in total dietary fiber content in food products. This study analyzed the fiber content of several enteral formulas, including one deemed “fiber free”, to showcase comparative fiber content across these two methods (AOAC 991.43, AOAC 2011.25).

Latest Research from ASPEN 2023 (P30)

Tolerance and Adherence to Home Enteral Nutrition Therapy based on Formula Category: Conventional versus Plant-based versus Blenderized

This retrospective review assessed the prevalence of formula changes for adult patients receiving home EN therapy from a home infusion company. The conventional formula group had overall more formula switches and switches due to intolerance in comparison to the plant-based and blenderized formula groups.

Latest Research from ASPEN 2023 (P33)

Improved GI Tolerance, Nutrition Provision, and Weight Maintenance in an Adult Patient with Cerebral Palsy, Secondary Dysphagia and Gastroparesis using a Standard Plant-Based Enteral Formula

This case study assessed tolerance and weight maintenance of an adult Cerebral Palsy (CP) patient with secondary dysphagia, G-tube dependence, and gastroparesis consuming a standard plant-based enteral formula (PBEF) at a single adult gastroenterology center.

Latest Research from ASPEN 2023 (P34)

Improved GI Tolerance, Quality of Life, and Weight Gain in an Adult Ulcerative Colitis, Renal Transplant Patient using a Plant-based Diabetes Specific Enteral Formula

This case study assessed tolerance, weight gain, and quality of life (QoL) in an adult Ulcerative Colitis (UC) patient status post renal transplant consuming a plant-based, fiber-containing diabetes specific enteral formula (PBDF) orally at a single adult gastroenterology center.

Latest Research from ASPEN 2023 (P51)

The Effect of a Plant Based Nutritional Supplement on Symptoms and Calorie- and Protein-Deficits in Patients with Gastroparesis

Adults with gastroparesis were given Kate Farms Peptide 1.5 to supplement their diet with an attempt to determine if improving protein deficit can improve patient symptoms. Weight, GCSI (gastroparesis cardinal symptom index) and PAGI-SYM were measured at baseline, week 4, and week 12.

Growth and Tolerance of Pediatric Patients Transitioned from Hypoallergenic Formula

The purpose of this study was to assess the growth and tolerance of pediatric patients who transitioned from a hypoallergenic formula to a pea protein plant-based formula (PPPBF).

Patient-Reported Outcomes of GI Symptoms and Adherence

The purpose of this study was to describe the specific symptom frequency of constipation, diarrhea, vomiting, bloating and adherence reported in pediatric patients who have been on a pea protein plant-based enteral formula (PP PBEF).

Weight Gain in Oncology Patients Using a Plant-Based Oral Nutrition Supplement¹

Research shows that 49-74% of oncology patients will experience unintentional weight loss at some point during their treatment².

Improved GI Tolerance and Weight Gain in Pediatric Patients

In this study, researchers at a pediatric GI clinic reviewed the charts of patients who had switched from their previous formula to Kate Farms within the previous 2 years.

Patient-Reported Outcomes Indicate Improved Nutrition and GI Symptoms

This study investigated patient-reported outcomes of pediatric and adult users of plant-based enteral formulas containing intact or hydrolyzed pea protein. A total of 392 patients and caregivers completed the online survey.

Plant-based Enteral Nutrition Tolerance and Benefit in Pediatric Crohn’s Disease

The purpose of this study was to assess the outcomes of three pediatric Crohn’s disease patients in clinical remission who were started on pediatric peptide plant-based enteral nutrition (PPBEN) in conjunction with Crohn’s disease exclusion diet (CDED).

Plant-Based Peptide with Phytonutrients Status Post Bone Marrow Transplant

The purpose of this study was to document the successful concomitant use of a plant-based, phytonutrient-containing enteral formula and immunosuppressive medications.

Clinician-Reported Outcomes of Patients Using a Plant‑Based Formula

A study on the usage and outcomes of pediatric and adult patients with a medical need for nutritional formula who had been prescribed a plant-based, organic, calorically dense peptide formula (Kate Farms® Peptide 1.5).

References:

1. Bailey, M., Millovich, V., Komar, S. Weight gain in oncology patients using a plant-based oral nutrition supplement. Clinical Nutrition ESPEN. 2020; 40:661.

2. Dufau L., (2010). Prevalence of malnutrition in cancer patients. Diaeta 28, 31–36.